Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?-Reference-Cited by-同舟云学术

Immune checkpoint blockade: releasing the breaks or a protective barrier to COVID-19 severe acute respiratory syndrome?

Published:2020-06-16 Issue:5 Volume:123 Page:691-693
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Pickles Oliver J.,Lee Lennard Y. W.,Starkey Thomas,Freeman-Mills Luke,Olsson-Brown Anna,Cheng Vinton,Hughes Daniel J.,Lee Alvin,Purshouse Karin,Middleton Gary

Abstract

SummaryThe rapid emergence of COVID-19 has sent shockwaves through healthcare systems globally, with cancer patients at increased risk. The interplay of the virus and host immune system has been implicated in the development of ARDS. Immunotherapy agents have the potential to adversely potentiate this phenomenon, requiring careful real-world observation.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-020-0930-7.pdf

Reference20 articles.

1. Kruger, S., Ilmer, M., Kobold, S., Cadilha, B. L., Endres, S., Ormanns, S., et al. Advances in cancer immunotherapy 2019 – latest trends. J. Exp. Clin. Cancer Res. 38, https://doi.org/10.1186/s13046-019-1266-0 (2019).

2. Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395, 565–574 (2020).

3. Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S. & Manson, J. J. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033–1034 (2020).

4. Han, S. & Mallampalli, R. K. The acute respiratory distress syndrome: from mechanism to translation. J. Immunol. 194, 855–860 (2015).

5. Tseng, C. T., Perrone, L. A., Zhu, H., Makino, S. & Peters, C. J. Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection. J. Immunol. 174, 7977–7985 (2005).

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of the immune environment in prostate cancer as an adjunct to immunotherapy;Health Science Reports;2024-07

2. An update on the pharmacological management of acute respiratory distress syndrome;Expert Opinion on Pharmacotherapy;2024-06-12

3. Anti-inflammatory therapies for acute respiratory distress syndrome;Expert Opinion on Investigational Drugs;2023-11-27

4. Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities;Vaccines;2022-10-07

5. “Role of kidney function and concentrations of BAFF, sPD-L1 and sCD25 on mortality in hospitalized patients with COVID-19”;BMC Nephrology;2022-09-02